Assignee profile:

Human Services

City:

Bethesda, Maryland

Country:

United States

Published Applications:

19

Last publication date:

2020-03-26

Patent Grants:

15

Last grant date:

2023-02-21

Top Inventors for applications by Human Services

These are the the leading inventors for applications assigned to Human Services:

Recent patent applications by Human Services

Human Services based in Bethesda, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2020-03-26 ✅ Patent 11,583,239 granted on 2023-02-21
US20200093455A1
Human necessities

Method and system of building hospital-scale chest X-ray database for entity extraction and weakly-supervised classification and localization of common thorax diseases

#2 | 2019-12-12 ✅ Patent 11,021,535 granted on 2021-06-01
US20190375831A1
Chemistry; metallurgy

Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use

#3 | 2018-09-27
US20180271788A1
Human necessities

VESICLE CONTAINING METALLIC NANOPARTICLE AND METHOD FOR PRODUCTION THEREOF

#4 | 2018-08-30 ✅ Patent 10,835,710 granted on 2020-11-17
US20180243530A1
Human necessities

Segmented MRI catheters and other interventional devices

#5 | 2018-06-14 ✅ Patent 10,954,492 granted on 2021-03-23
US20180163182A1
Chemistry; metallurgy

Processes for production and purification of nucleic acid-containing compositions

#6 | 2017-07-20 ✅ Patent 9,919,058 granted on 2018-03-20
US20170202977A1
Human necessities

Polyketal particles including a CpG oligodeoxynucleotide for the treatment of lung cancer

#7 | 2015-10-22 ✅ Patent 9,664,682 granted on 2017-05-30
US20150301057A1
Physics

Assay to measure midkine or pleiotrophin level for diagnosing a growth

#8 | 2014-06-19 ✅ Patent 10,071,945 granted on 2018-09-11
US20140171503A1
Chemistry; metallurgy

Nuclear receptor modulators and their use for the treatment and prevention of cancer

#9 | 2014-02-13 ✅ Patent 9,402,820 granted on 2016-08-02
US20140045796A1
Human necessities

Use of pyruvate or succinate to enhance the efficacy of a hypoxia activated prodrug for the treatment of tumors

#10 | 2014-01-30 ✅ Patent 9,074,185 granted on 2015-07-07
US20140030806A1
Chemistry; metallurgy

Adoptive cell therapy with young T cells

#11 | 2014-01-23
US20140024013A1
Chemistry; metallurgy

Isolation, Cloning and Characterization of New Adeno-Associated Virus (AAV) Serotypes

#12 | 2013-09-12 ✅ Patent 8,710,026 granted on 2014-04-29
US20130237587A1
Human necessities

MiR 204, miR 211, their anti-miRs, and therapeutic uses of same

#13 | 2013-01-24 ✅ Patent 8,609,716 granted on 2013-12-17
US20130023500A1
Chemistry; metallurgy

Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof

#14 | 2012-10-04 ✅ Patent 8,685,722 granted on 2014-04-01
US20120253018A1
Chemistry; metallurgy

Bovine adeno-associated viral (BAAV) vector and uses thereof

#15 | 2011-06-23 ✅ Patent 8,816,059 granted on 2014-08-26
US20110152355A1
Chemistry; metallurgy

Method for predicting and detecting tumor metastasis

#16 | 2011-06-23
US20110152115A1
Chemistry; metallurgy

METHODS FOR IDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMAS

#17 | 2011-02-03 ✅ Patent 8,030,280 granted on 2011-10-04
US20110027299A1
Chemistry; metallurgy

Melanoma antigens and their use in diagnostic and therapeutic methods

#18 | 2010-10-21
US20100267712A1
Chemistry; metallurgy

ISOINDOLINE COMPOUNDS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY AND OTHER USES

#19 | 2010-10-07 ✅ Patent 8,957,188 granted on 2015-02-17
US20100254898A1
Human necessities

Antibodies that bind GalNAc1-3Gal, pharmaceutical compositions and methods of using same

AssigneeID:

6092 ⎘